Analyze Diet
Equine veterinary journal2026; doi: 10.1002/evj.70314

Phylogenetic and phylogeographic analysis of equine influenza in Colombia.

Abstract: In 2022, Colombia experienced an outbreak of equine influenza (EI) that primarily affected competition horses. Despite the epidemiological relevance of equine influenza virus (EIV) in the country, no previous phylogenetic or phylogeographic analyses based on complete genomes have been reported. Objective: To perform phylogenetic and phylogeographic analyses of complete EIV genomes obtained from horses with clinical signs in two Colombian regions between 2020 and 2023. Methods: Molecular epidemiological study based on whole-genome sequencing and evolutionary analyses. Methods: Nasopharyngeal samples were collected from horses presenting clinical signs compatible with EI. Infection was confirmed by quantitative PCR (qPCR). Two complete EIV genomes were generated using Oxford Nanopore sequencing technology. Phylogenetic relationships were inferred using reference sequences from global databases. Time-scaled phylogenetic analyses were conducted to estimate the time to the most recent common ancestor (tMRCA). Amino acid substitutions were analysed across all gene segments. Results: Two complete EIV genomes were obtained. Both sequences shared >90% nucleotide identity with contemporary strains circulating in the United States, including A/equine/Missouri/1/2022 (H3N8), A/equine/Florida/2/2022 (H3N8), and Ohio/OH21-6023/2021 (H3N8). A time-scaled analysis estimated a tMRCA in 2020 (95% highest posterior density interval: 2019-2021). A greater number of amino acid substitutions were identified in the HA and NA genes, followed by those in PB2, PA, and PB1, including novel substitutions in the Colombian sequences. Conclusions: The limited number of complete genomes restricts inference regarding nationwide viral diversity and transmission dynamics. Conclusions: Colombian EIV strains are closely related to recent North American lineages, supporting the role of international horse movement in viral introduction and dissemination. These findings underscore the importance of genomic surveillance for monitoring viral evolution and informing prevention strategies.
Publication Date: 2026-08-26 PubMed ID: 42644280DOI: 10.1002/evj.70314Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • Researchers analyzed the genetic makeup and geographic spread of equine influenza virus (EIV) strains from horses in Colombia between 2020 and 2023.
  • The study identified that Colombian EIV strains are closely related to recent North American strains, suggesting international horse movement contributed to virus spread.

Background and Objective

  • Equine influenza (EI) is a significant respiratory disease affecting horses, with outbreaks causing notable economic and animal health impacts.
  • In 2022, Colombia experienced an EI outbreak mainly in competition horses.
  • Before this study, there were no comprehensive analyses of complete EIV genomes from Colombian cases to understand virus evolution and spread.
  • The objective was to perform phylogenetic (genetic relatedness) and phylogeographic (geographic distribution of genetic lineages) analyses of whole EIV genomes sampled from Colombian horses showing clinical signs of EI.

Methods

  • Clinical sampling: Nasopharyngeal swabs were collected from horses in two Colombian regions exhibiting symptoms consistent with EI.
  • Confirmation of infection was done using quantitative PCR (qPCR), a molecular technique to detect viral RNA.
  • Whole-genome sequencing of the virus was performed using Oxford Nanopore technology, an advanced sequencing method that reads long strands of viral genetic material.
  • Phylogenetic analysis involved comparing the obtained Colombian virus genomes to reference sequences from global public databases to infer genetic relationships.
  • Time-scaled phylogenetic analyses estimated the time to the most recent common ancestor (tMRCA), indicating when genetically related viruses last shared a common ancestor.
  • Amino acid substitution analysis checked for genetic changes across all gene segments, focusing on viral proteins integral to infection and immune recognition.

Key Results

  • Two complete EIV genomes were successfully obtained from sampled horses.
  • Genomic comparison showed over 90% nucleotide identity with strains circulating recently in the United States, specifically strains A/equine/Missouri/1/2022 (H3N8), A/equine/Florida/2/2022 (H3N8), and Ohio/OH21-6023/2021 (H3N8).
  • The estimated tMRCA of the sampled viruses was around 2020, with a confidence interval from 2019 to 2021, suggesting recent divergence from North American strains.
  • Notable amino acid changes were identified, particularly in the hemagglutinin (HA) and neuraminidase (NA) genes, which are critical surface proteins involved in viral entry and exit from host cells.
  • Other significant substitutions were observed in internal gene segments coding for polymerase proteins (PB2, PA, PB1).
  • Some amino acid changes were novel and unique to the Colombian sequences, hinting at local viral evolution after introduction.

Conclusions

  • The study revealed that Colombian EIV strains are genetically similar to recent North American strains, indicating the key role of international horse movement (such as transport of competition horses) in introducing and spreading EI in Colombia.
  • The limited number of complete genome sequences restricts comprehensive understanding of viral diversity and transmission dynamics across the entire country.
  • The identification of unique amino acid changes underscores the importance of ongoing genomic surveillance to detect viral evolution that could affect virulence or vaccine effectiveness.
  • This research supports the need for enhanced monitoring and prevention strategies in Colombia, especially given international horse movement, to better control equine influenza outbreaks.

Cite This Article

APA
Gonzalez-Obando J, Carrillo M, Diaz FJ, Garvey M, Usuga J, Moreno I, Hernandez-Ortiz JP, Forero JE, Diaz A, Rojas-Arbeláez C, Cullinane A, Ruiz-Saenz J. (2026). Phylogenetic and phylogeographic analysis of equine influenza in Colombia. Equine Vet J. https://doi.org/10.1002/evj.70314

Publication

ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English

Researcher Affiliations

Gonzalez-Obando, Juliana
  • Grupo de Investigación en Ciencias Animales-GRICA, Facultad de Medicina Veterinaria y Zootecnia, Universidad Cooperativa de Colombia, Bucaramanga, Colombia.
  • Grupo de Epidemiología, Universidad de Antioquia, Medellín, Colombia.
Carrillo, Marlen
  • Grupo de Investigación en Ciencias Animales-GRICA, Facultad de Medicina Veterinaria y Zootecnia, Universidad Cooperativa de Colombia, Bucaramanga, Colombia.
Diaz, Francisco J
  • Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia.
Garvey, Marie
  • Virology Unit, The Irish Equine Centre, Johnstown, Ireland.
Usuga, Jaime
  • One Health Genomic Laboratory, National University of Colombia, Medellín, Colombia.
Moreno, Isabel
  • One Health Genomic Laboratory, National University of Colombia, Medellín, Colombia.
Hernandez-Ortiz, Juan Pablo
  • One Health Genomic Laboratory, National University of Colombia, Medellín, Colombia.
Forero, Jorge E
  • Grupo de Investigación en Microbiología Ambiental, Escuela de Microbiología, Universidad de Antioquia, Medellín, Colombia.
Diaz, Andrés
  • Pig Improvement Company, Hendersonville, Tennessee, USA.
Rojas-Arbeláez, Carlos
  • Grupo de Epidemiología, Universidad de Antioquia, Medellín, Colombia.
Cullinane, Ann
  • Virology Unit, The Irish Equine Centre, Johnstown, Ireland.
Ruiz-Saenz, Julian
  • Grupo de Investigación en Ciencias Animales-GRICA, Facultad de Medicina Veterinaria y Zootecnia, Universidad Cooperativa de Colombia, Bucaramanga, Colombia.

Grant Funding

  • INV2623 to J.R.-S. / CONADI-UCC

References

This article includes 63 references
  1. Aguirre‐Ezkauriatza EJ, Karlsson EA, Freiden P, Schultz‐Cherry S, Flores‐Gutierrez SGH, Zertuche‐Guerra MI. Seroepidemiological survey of equine influenza a H3N8 in horses from the eastern region of the United States‐Mexico border. J Anim Vet Adv 2012;11(13):2250–2255.
  2. Nemoto M, Kawanishi N, Kambayashi Y, Bannai H, Yamanaka T, Tsujimura K. Detection of equine influenza virus gene in the air around infected horses. Vet Microbiol 2025;302:110388.
  3. Gonzalez‐Obando J, Forero JE, Zuluaga‐Cabrera AM, Ruiz‐Saenz J. Equine influenza virus: an old known enemy in the Americas. Vaccines (Basel) 2022;10(10):1718.
  4. Gildea S, Lyons P, Lyons R, Gahan J, Garvey M, Cullinane A. Annual booster vaccination and the risk of equine influenza to Thoroughbred racehorses. Equine Vet J 2020;52(4):509–515.
  5. Wu NC, Wilson IA. Influenza hemagglutinin structures and antibody recognition. Cold Spring Harb Perspect Med 2020;10(8):a038778.
  6. Murcia PR, Wood JL, Holmes EC. Genome‐scale evolution and phylodynamics of equine H3N8 influenza A virus. J Virol 2011;85(11):5312–5322.
  7. Chambers TM. Equine influenza. Cold Spring Harb Perspect Med 2022;12(1):a038331.
  8. Kleij L, Bruder E, Raoux‐Barbot D, Lejal N, Nevers Q, Deloizy C. Genomic characterization of equine influenza A subtype H3N8 viruses by long read sequencing and functional analyses of the PB1‐F2 virulence factor of A/equine/Paris/1/2018. Vet Res 2024;55(1):36.
  9. Fougerolle S, Fortier C, Legrand L, Jourdan M, Marcillaud‐Pitel C, Pronost S. Success and limitation of equine influenza vaccination: the first incursion in a decade of a Florida clade 1 equine influenza virus that shakes protection despite high vaccine coverage. Vaccine 2019;7(4):174.
  10. De Vlugt C, Sikora D, Pelchat M. Insight into influenza: a virus cap‐snatching. Viruses 2018;10(11):641.
  11. Szewczyk B, Bieńkowska‐Szewczyk K, Król E. Introduction to molecular biology of influenza a viruses. Acta Biochim Pol 2014;61(3):397–401.
  12. Hara K, Schmidt FI, Crow M, Brownlee GG. Amino acid residues in the N‐terminal region of the PA subunit of influenza A virus RNA polymerase play a critical role in protein stability, endonuclease activity, cap binding, and virion RNA promoter binding. J Virol 2006;80(16):7789–7798.
  13. Gahan J, Garvey M, Asmah Abd Samad R, Cullinane A. Whole genome sequencing of the first H3N8 equine influenza virus identified in Malaysia. Pathogens 2019;8(2):62.
  14. Gahan J, Garvey M, Gildea S, Gür E, Kagankaya A, Cullinane A. Whole‐genome sequencing and antigenic analysis of the first equine influenza virus identified in Turkey. Influenza Other Respi Viruses 2018;12(3):374–382.
  15. Miño S, Mojsiejczuk L, Guo W, Zhang H, Qi T, Du C. Equine influenza virus in Asia: phylogeographic pattern and molecular features reveal circulation of an autochthonous lineage. J Virol 2019;93(13):e00116‐19.
    doi: 10.1128/jvi.00116-19google scholar: lookup
  16. Lee K, Pusterla N, Barnum SM, Lee DH, Martínez‐López B. Genome‐informed characterisation of antigenic drift in the haemagglutinin gene of equine influenza strains circulating in the United States from 2012 to 2017. Transbound Emerg Dis 2022;69(4):e52–e63.
  17. Legrand L, Pitel PH, Marcillaud‐Pitel C, Cullinane A, Couroucé A, Fortier G. Surveillance of equine influenza viruses through the RESPE network in France from November 2005 to October 2010. Equine Vet J 2013;45(6):776–783.
  18. Webster WR. Overview of the 2007 Australian outbreak of equine influenza. Aust Vet J 2011;89(Suppl 1):3–4.
  19. Smyth G, Dagley K, Tainsh J. Insights into the economic consequences of the 2007 equine influenza outbreak in Australia. Aust Vet J 2011;89:151–158.
  20. Diallo AA, Souley MM, Issa Ibrahim A, Alassane A, Issa R, Gagara H. Transboundary spread of equine influenza viruses (H3N8) in West and Central Africa: molecular characterization of identified viruses during outbreaks in Niger and Senegal, in 2019. Transbound Emerg Dis 2021;68(3):1253–1262.
  21. Cullinane A, Newton JR. Equine influenza—a global perspective. Vet Microbiol 2013;167(1–2):205–214.
  22. Cullinane A, Elton D, Mumford J. Equine influenza—surveillance and control. Influenza Other Respi Viruses 2010;4(6):339–344.
  23. Olguin‐Perglione C, Vissani MA, Alamos F, Tordoya MS, Barrandeguy M. Multifocal outbreak of equine influenza in vaccinated horses in Argentina in 2018: epidemiological aspects and molecular characterisation of the involved virus strains. Equine Vet J 2020;52(3):420–427.
  24. Agropecuario IC. Funcionarios del ICA continúan trabajando para detectar y controlar brote de influenza equina Colombia. 2018 [cited 2025 Feb 23]. Available from: https://www.ica.gov.co/noticias/ica-trabaja-detectar-controlar-influenza-equina
  25. Gonzalez‐Obando J, Jaimes‐Dueñez J, Zuluaga‐Cabrera A, Forero JE, Diaz A, Rojas‐Arbeláez C. Seroprevalence of equine influenza virus antibodies in horses from four localities in Colombia. Viruses 2025;17(7):999.
  26. Heine H, Trinidad L, Selleck P, Lowther S. Rapid detection of highly pathogenic avian influenza H5N1 virus by Taqman RT‐PCR. Avian Dis Dig 2007;2(Suppl 1):e40.
  27. Mena J, Brito B, Moreira R, Tadich T, Gonzalez I, Cruces J. Reemergence of H3N8 equine influenza A virus in Chile, 2018. Transbound Emerg Dis 2018;65(6):1408–1415.
  28. King J, Harder T, Beer M, Pohlmann A. Rapid multiplex MinION nanopore sequencing workflow for influenza A viruses. BMC Infect Dis 2020;20(1):648.
  29. Wang J, Moore NE, Deng Y‐M, Eccles DA, Hall RJ. MinION nanopore sequencing of an influenza genome. Front Microbiol 2015;6:766.
  30. Prime G. Geneious prime 2024. 2024.
  31. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol 2013;30(12):2725–2729.
  32. Bouckaert R, Heled J, Kühnert D, Vaughan T, Wu C‐H, Xie D. BEAST 2: a software platform for Bayesian evolutionary analysis. PLoS Comput Biol 2014;10(4):e1003537.
  33. Rambaut A, Suchard M, Xie D, Drummond AJ. Tracer v1. 6. Edinburgh: Tracer; 2013.
  34. Rambaut A. FigTree, version 1.4.4. 2018.
  35. Favaro PF, Fernandes WR, Reischak D, Brandão PE, Silva SOS, Richtzenhain LJ. Evolution of equine influenza viruses (H3N8) during a Brazilian outbreak, 2015. Braz J Microbiol 2018;49:336–346.
  36. Feng KH, Gonzalez G, Deng L, Yu H, Tse VL, Huang L. Equine and canine influenza H3N8 viruses show minimal biological differences despite phylogenetic divergence. J Virol 2015;89(13):6860–6873.
  37. Olguin Perglione C, Golemba MD, Torres C, Barrandeguy M. Molecular epidemiology and spatio‐temporal dynamics of the H3N8 equine influenza virus in South America. Pathogens (Basel) 2016;5(4):61.
  38. Sreenivasan CC, Jandhyala SS, Luo S, Hause BM, Thomas M, Knudsen DE. Phylogenetic analysis and characterization of a sporadic isolate of equine influenza A H3N8 from an unvaccinated horse in 2015. Viruses 2018;10(1):31.
  39. Bountouri M, Fragkiadaki E, Ntafis V, Kanellos T, Xylouri E. Phylogenetic and molecular characterization of equine H3N8 influenza viruses from Greece (2003 and 2007): evidence for reassortment between evolutionary lineages. Virol J 2011;8:1–9.
  40. Ricci I, Tofani S, Lelli D, Vincifori G, Rosone F, Carvelli A. First reported circulation of equine influenza H3N8 Florida clade 1 virus in horses in Italy. Animals 2024;14(4):598.
  41. Lewis N, Daly J, Russell C, Horton D, Skepner E, Bryant N. Antigenic and genetic evolution of equine influenza A (H3N8) virus from 1968 to 2007. J Virol 2011;85(23):12742–12749.
  42. Ding J, Wang Y, Liang J, He Z, Zhai C, He Y. Spatiotemporal pattern and suitable areas analysis of equine influenza in global scale (2005–2022). Front Vet Sci 2024;11:1395327.
  43. Turcotte G, O'Sullivan TL, Rossi T, Spence KL, Winder CB, Greer AL. Integration of empirical network data and agent‐based modelling to examine the risk of equine influenza infection in equine athletes in Ontario, Canada. Prev Vet Med 2025;245:106665.
  44. Van Galen G. Epidemiology and control of infectious respiratory disease in populations of athletic horses. Equine sports medicine and surgery London: Saunders Ltd; 2024. p. 775–799.
  45. Asare DA, Kwem KB, Bediako SO, Emikpe BO, Rodgers D, Odoom T. Status of equine influenza virus in horses in Accra metropolis in the Greater‐Accra Region, Ghana. PAMJ‐One Health 2024;15(18):45242.
  46. Gonzalez‐Obando J, Zuluaga‐Cabrera A, Moreno I, Úsuga J, Ciuderis K, Forero JE. First molecular detection and epidemiological analysis of equine influenza virus in two regions of Colombia, 2020–2023. Viruses 2024;16(6):839.
  47. Kareche H, Valle‐Casuso J‐C, Madeline A, Froger D, Lecouturier F, Gonzalez G. Equine influenza outbreak in eastern of Algeria in 2021: the first introduction of Florida clade 1 to Maghreb area. Comp Immunol Microbiol Infect Dis 2024;104:102109.
  48. Pulkina A, Vasilyev K, Muzhikyan A, Sergeeva M, Romanovskaya‐Romanko E, Shurygina A‐P. IgGκ signal peptide enhances the efficacy of an influenza vector vaccine against respiratory syncytial virus infection in mice. Int J Mol Sci 2023;24(14):11445.
  49. Collins PJ, Vachieri SG, Haire LF, Ogrodowicz RW, Martin SR, Walker PA. Recent evolution of equine influenza and the origin of canine influenza. Proc Natl Acad Sci 2014;111(30):11175–11180.
  50. Wasik BR, Rothschild E, Voorhees IE, Reedy SE, Murcia PR, Pusterla N. Understanding the divergent evolution and epidemiology of H3N8 influenza viruses in dogs and horses. Virus Evol 2023;9(2):vead052.
  51. Murcia PR, Baillie GJ, Stack JC, Jervis C, Elton D, Mumford JA. Evolution of equine influenza virus in vaccinated horses. J Virol 2013;87(8):4768–4771.
  52. McAuley JL, Gilbertson BP, Trifkovic S, Brown LE, McKimm‐Breschkin JL. Influenza virus neuraminidase structure and functions. Front Microbiol 2019;10:39.
  53. Rash A, Woodward A, Bryant N, McCauley J, Elton D. An efficient genome sequencing method for equine influenza [H3N8] virus reveals a new polymorphism in the PA‐X protein. Virol J 2014;11:1–9.
  54. Nemoto M, Reedy SE, Yano T, Suzuki K, Fukuda S, Garvey M. Antigenic comparison of H3N8 equine influenza viruses belonging to Florida sublineage clade 1 between vaccine strains and North American strains isolated in 2021–2022. Arch Virol 2023;168(3):94.
  55. Kerry PS, Willsher N, Fodor E. A cluster of conserved basic amino acids near the C‐terminus of the PB1 subunit of the influenza virus RNA polymerase is involved in the regulation of viral transcription. Virology 2008;373(1):202–210.
  56. Te Velthuis AJ, Fodor E. Influenza virus RNA polymerase: insights into the mechanisms of viral RNA synthesis. Nat Rev Microbiol 2016;14(8):479–493.
  57. Li ML, Rao P, Krug RM. The active sites of the influenza cap‐dependent endonuclease are on different polymerase subunits. EMBO J 2001;20:2078–2086.
  58. Hatta M, Gao P, Halfmann P, Kawaoka Y. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 2001;293(5536):1840–1842.
  59. Bountouri M, Ntafis V, Fragkiadaki E, Kanellos T, Xylouri E. Phylogenetic analysis of the five internal genes and evolutionary pathways of the Greek H3N8 equine influenza virus. Nat Sci 2012;4:839–847.
  60. Kwasnik M, Gora IM, Rola J, Zmudzinski JF, Rozek W. NS‐gene based phylogenetic analysis of equine influenza viruses isolated in Poland. Vet Microbiol 2016;182:95–101.
  61. Chambers TM, Quinlivan M, Sturgill T, Cullinane A, Horohov DW, Zamarin D. Influenza A viruses with truncated NS1 as modified live virus vaccines: pilot studies of safety and efficacy in horses. Equine Vet J 2009;41(1):87–92.
  62. Nemoto M, Ohta M, Yamanaka T, Kambayashi Y, Bannai H, Tsujimura K. Antigenic differences between equine influenza virus vaccine strains and Florida sublineage clade 1 strains isolated in Europe in 2019. Vet J 2021;272:105674.
  63. Pellegrini F, Buonavoglia A, Omar AH, Diakoudi G, Lucente MS, Odigie AE. A cold case of equine influenza disentangled with nanopore sequencing. Animals 2023;13(7):1153.

Citations

This article has been cited 0 times.